Seeking Alpha

Abbott Laboratories (ABT)

()

Instablog posts on ABT

  • Dividend strategy by TLassen
    From www.cnbc.com/id/34046554If You Like Dividends, You May Love These 9 StocksGary Kaminsky is a skeptic. “I think to buy stocks based on dividend yields is a loser's game," he says. "If interest rates go up next year as I suspect they will, these stocks will be negatively... More »
    November 20, 2009 • T, VZ, LO
  • Dividend Achiever Recommendation Review by Dividend Inc
    On October 9, 2009, I created a list of ten Dividend Achievers that I felt were the best investments at the time. After having passed the 1 month period, I feel that it is necessary to review the performance of the stocks that were on that list. As with the original article I will show the... More »
    November 14, 2009 • WMT, CAH, BCR
  • Kendle International Healthcare by Michael Michaud
    The Market Last Week and AheadFirst, the most important date report in the financial universe, the US Non-Farm Payroll Report is Friday. Last Friday authorities seized nine US banks. If people continue to carry trade the dollar and if they start to unwind those trades more traders and investors... More »
    November 2, 2009 • KNDL, CVD, PRXL
  • Chembio Diagnostics: A buyer's delight by Jospeh Krueger
    Medical diagnostics may not seem as glamorous a field like pharmaceuticals or medical devices, but it sure is a profitable one. In-vitro medical diagnostics is currently a $40 billion dollar market that provides revenue multi-billion dollar companies like BioRad (BIO), Abbott (ABT), Beckman... More »
    October 28, 2009 • BIO, ABT, BEC
  • (?) AGAM priced 37.5% under original range mid-point by IPOdesktop
    The underwriters totally misestimated the pricing, probably because of pressure from selling shareholders.Very unusual to have price decrease, pre-IPO & have the selling shareholders up their number of shares by almost 40%.read more in IPO report, adjusted for IPO price of... More »
    October 21, 2009 • AGAM, BSX, STJ
  • C.R Bard (BCR) by Peter Mycroft Psaras
    The Following shows the year end prices for the last 24 years (except 2009) for one of my favorite stocks, C.R. Bard (BCR). A $10,000 investment in BCR in 1985 would be worth $573,037 today for a total return on your investment of 5,630%.  BCR has also returned an average annual return of... More »
    October 19, 2009 • STJ, BSX, JNJ
  • AGA Medical (AGAM) IPO expected this week, $960mm market cap by IPOdesktop
    Scheduled to price $275mm Tuesday, trade Wednesday, Oct 21. High 82% gross margin. Declining net income. Shows loss for six months ended June 30. Highly leveraged (too much debt)Read more http://www.gaskinsco.com/linkto-aga.shtml More »
    October 19, 2009 • BSX, STJ, JNJ
  • What the Market Wants: Breaking Out or Topping Out? by David Brown
    (Monday, October 12, 2009  4:55 pm)   All major indices closed at or very near 2009 highs on Friday as the week featured a combination of better-than-expected economic news and a sprinkling of early earnings announcements on the plus side. From a technical perspective, the market... More »
    October 12, 2009 • COST, HE, HITK
  • M&A Deals Boost Stocks by MyHappyTrading.com
    This morning, the market opened higher, encouraged by M&A deals.  Xerox (XRX) announced a $6.5 billion deal to buy ACS.  XRX shares dropped 14.48% while ACS jumped +14.%.  Abbott Laboratories (ABT) said it would pay $6.6 billion for the pharmaceutical business of Belgian... More »
    September 29, 2009 • XRX, ACS, ABT
  • CDTV.net Stock Market News and Dividend Report for Monday Sep 28, 2009 by John Hanna
     Xerox Corporation (NYSE: XRX) to Acquire Affiliated Computer Services for $6.4 billion.  Ursula M. Burns, Xerox chief executive officer said "The revenue we generate from services will triple from $3.5 billion in 2008 to an estimated $10 billion next year." Xerox... More »
    September 28, 2009 • XRX, JNJ, ABT

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.